Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

New and emerging treatments in dermatology: acne

New and emerging treatments in dermatology: acne ABSTRACT: Topical retinoids, benzoyl peroxide, azelaic acid, and topical and oral antibiotics remain the milestone of treatment for mild to moderate acne vulgaris. Oral isotretinoin is useful for the treatment of severe nodular acne, treatment‐resistant acne, and acne with a risk of physical or psychological scarring. Hormonal treatment in female acne is useful in resistant or late‐onset acne. With increasing concerns regarding teratogenicity of isotretinoin and increasing antibiotic resistance, there is a clear need for therapeutic alternatives to these long‐used treatments. Research in the pathogenesis of acne has allowed for new therapies and future perspectives regarding acne to evolve. They include low‐dose long‐term isotretinoin regimens, insulin‐sensitizing agents, 5α‐reductase type 1 inhibitors, topical photodynamic therapy, new combination formulations, dietary interventions, and antiinflammatory agents such as lipoxygenase inhibitors. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Dermatologic Therapy Wiley

New and emerging treatments in dermatology: acne

Dermatologic Therapy , Volume 21 (2) – Mar 1, 2008

Loading next page...
 
/lp/wiley/new-and-emerging-treatments-in-dermatology-acne-e7EJ2KMrbq

References (103)

Publisher
Wiley
Copyright
Copyright © 2008
ISSN
1396-0296
eISSN
1529-8019
DOI
10.1111/j.1529-8019.2008.00175.x
pmid
18394082
Publisher site
See Article on Publisher Site

Abstract

ABSTRACT: Topical retinoids, benzoyl peroxide, azelaic acid, and topical and oral antibiotics remain the milestone of treatment for mild to moderate acne vulgaris. Oral isotretinoin is useful for the treatment of severe nodular acne, treatment‐resistant acne, and acne with a risk of physical or psychological scarring. Hormonal treatment in female acne is useful in resistant or late‐onset acne. With increasing concerns regarding teratogenicity of isotretinoin and increasing antibiotic resistance, there is a clear need for therapeutic alternatives to these long‐used treatments. Research in the pathogenesis of acne has allowed for new therapies and future perspectives regarding acne to evolve. They include low‐dose long‐term isotretinoin regimens, insulin‐sensitizing agents, 5α‐reductase type 1 inhibitors, topical photodynamic therapy, new combination formulations, dietary interventions, and antiinflammatory agents such as lipoxygenase inhibitors.

Journal

Dermatologic TherapyWiley

Published: Mar 1, 2008

There are no references for this article.